Literature DB >> 29368244

Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT.

Valerio Nardone1,2, Paolo Tini3,4,5, Christophe Nioche6, Maria Antonietta Mazzei3,7, Tommaso Carfagno3,4, Giuseppe Battaglia3,4, Pierpaolo Pastina3,4, Roberta Grassi8, Lucio Sebaste3,4, Luigi Pirtoli3,4,9.   

Abstract

PURPOSE: Image texture analysis (TA) is a heterogeneity quantifying approach that cannot be appreciated by the naked eye, and early evidence suggests that TA has great potential in the field of oncology. The aim of this study is to evaluate parotid gland texture analysis (TA) combined with formal dosimetry as a factor for predicting severe late xerostomia in patients undergoing radiation therapy for head and neck cancers.
METHODS: We performed a retrospective analysis of patients treated at our Radiation Oncology Unit between January 2010 and December 2015, and selected the patients whose normal dose constraints for the parotid gland (mean dose < 26 Gy for the bilateral gland) could not be satisfied due to the presence of positive nodes close to the parotid glands. The parotid gland that showed the higher V30 was contoured on CT simulation and analysed with LifeX Software©. TA parameters included features of grey-level co-occurrence matrix (GLCM), neighbourhood grey-level dependence matrix (NGLDM), grey-level run length matrix (GLRLM), grey-level zone length matrix (GLZLM), sphericity, and indices from the grey-level histogram. We performed a univariate and multivariate analysis between all the texture parameters, the volume of the gland, the normal dose parameters (V30 and Mean Dose), and the development of severe chronic xerostomia.
RESULTS: Seventy-eight patients were included and 25 (31%) developed chronic xerostomia. The TA parameters correlated with severe chronic xerostomia included V30 (OR 5.63), Dmean (OR 5.71), Kurtosis (OR 0.78), GLCM Correlation (OR 1.34), and RLNU (OR 2.12). The multivariate logistic regression showed a significant correlation between V30 (0.001), GLCM correlation (p: 0.026), RLNU (p: 0.011), and chronic xerostomia (p < 0.001, R2:0.664).
CONCLUSIONS: Xerostomia represents an important cause of morbidity for head and neck cancer survivors after radiation therapy, and in certain cases normal dose constraints cannot be satisfied. Our results seem promising as texture analysis could enhance the normal dose constraints for the prediction of xerostomia.

Entities:  

Keywords:  Head and neck cancer; Radiation therapy; Texture analysis; Xerostomia

Mesh:

Year:  2018        PMID: 29368244     DOI: 10.1007/s11547-017-0850-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  43 in total

1.  Texture analysis to assess structural modifications induced by radiotherapy.

Authors:  E Scalco; S Moriconi; G Rizzo
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015

2.  Quality of life and oral function following radiotherapy for head and neck cancer.

Authors:  J B Epstein; S Emerton; D A Kolbinson; N D Le; N Phillips; P Stevenson-Moore; D Osoba
Journal:  Head Neck       Date:  1999-01       Impact factor: 3.147

3.  Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters.

Authors:  Claudio Fiorino; Giovanna Rizzo; Elisa Scalco; Sara Broggi; Maria Luisa Belli; Italo Dell'Oca; Nicola Dinapoli; Francesco Ricchetti; Aldo Mejia Rodriguez; Nadia Di Muzio; Riccardo Calandrino; Giuseppe Sanguineti; Vincenzo Valentini; Giovanni Mauro Cattaneo
Journal:  Radiother Oncol       Date:  2012-07-16       Impact factor: 6.280

4.  Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis.

Authors:  Valerio Nardone; Paolo Tini; Christophe Nioche; Michelangelo Biondi; Lucio Sebaste; Maria Antonietta Mazzei; Fabrizio Banci Buonamici; Luigi Pirtoli
Journal:  Radiother Oncol       Date:  2017-02       Impact factor: 6.280

5.  Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures.

Authors:  V Nardone; P Tini; S F Carbone; A Grassi; M Biondi; L Sebaste; T Carfagno; E Vanzi; G De Otto; G Battaglia; G Rubino; P Pastina; G Belmonte; L N Mazzoni; F Banci Buonamici; M A Mazzei; L Pirtoli
Journal:  Osteoporos Int       Date:  2017-02-27       Impact factor: 4.507

6.  The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy.

Authors:  F van Acker; P Flamen; P Lambin; A Maes; G J Kutcher; C Weltens; R Hermans; J Baetens; P Dupont; A Rijnders; A Maes; W van den Bogaert; L Mortelmans
Journal:  Nucl Med Commun       Date:  2001-02       Impact factor: 1.690

7.  Histopathological changes in parotid and submandibular glands of patients treated with preoperative chemoradiation therapy for oral cancer.

Authors:  Keiko Teshima; Ryuji Murakami; Ryoji Yoshida; Hideki Nakayama; Akimitsu Hiraki; Toshinori Hirai; Yuji Nakaguchi; Naoko Tsujita; Etsushi Tomitaka; Mitsuhiro Furusawa; Yasuyuki Yamashita; Masanori Shinohara
Journal:  J Radiat Res       Date:  2012-04-09       Impact factor: 2.724

8.  Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study.

Authors:  Anne S McMillan; Edmond H N Pow; Dora L W Kwong; May C M Wong; Jonathan S T Sham; Lucullus H T Leung; W Keung Leung
Journal:  Head Neck       Date:  2006-08       Impact factor: 3.147

Review 9.  Prevention and treatment of the consequences of head and neck radiotherapy.

Authors:  A Vissink; F R Burlage; F K L Spijkervet; J Jansma; R P Coppes
Journal:  Crit Rev Oral Biol Med       Date:  2003

10.  A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.

Authors:  Valesca P Retèl; Lisette van der Molen; Frans J M Hilgers; Coen R N Rasch; Annemiek A A M H J L'Ortye; Lotte M G Steuten; Wim H van Harten
Journal:  BMC Cancer       Date:  2011-11-03       Impact factor: 4.430

View more
  19 in total

1.  The role of delta radiomics in gastric cancer.

Authors:  Maria Antonietta Mazzei; Valerio Nardone; Letizia Di Giacomo; Giulio Bagnacci; Francesco Gentili; Paolo Tini; Daniele Marrelli; Luca Volterrani
Journal:  Quant Imaging Med Surg       Date:  2018-08

2.  A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.

Authors:  Kuo Men; Huaizhi Geng; Haoyu Zhong; Yong Fan; Alexander Lin; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-13       Impact factor: 7.038

3.  Benchmarking Various Radiomic Toolkit Features While Applying the Image Biomarker Standardization Initiative toward Clinical Translation of Radiomic Analysis.

Authors:  Mingxi Lei; Bino Varghese; Darryl Hwang; Steven Cen; Xiaomeng Lei; Bhushan Desai; Afshin Azadikhah; Assad Oberai; Vinay Duddalwar
Journal:  J Digit Imaging       Date:  2021-09-20       Impact factor: 4.903

4.  Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab.

Authors:  Valerio Nardone; Paolo Tini; Pierpaolo Pastina; Cirino Botta; Alfonso Reginelli; Salvatore Francesco Carbone; Rocco Giannicola; Grazia Calabrese; Carmela Tebala; Cesare Guida; Aldo Giudice; Vito Barbieri; Pierfrancesco Tassone; Pierosandro Tagliaferri; Salvatore Cappabianca; Rosanna Capasso; Amalia Luce; Michele Caraglia; Maria Antonietta Mazzei; Luigi Pirtoli; Pierpaolo Correale
Journal:  Oncol Lett       Date:  2019-12-16       Impact factor: 2.967

5.  Delta-radiomics increases multicentre reproducibility: a phantom study.

Authors:  Valerio Nardone; Alfonso Reginelli; Cesare Guida; Maria Paola Belfiore; Michelangelo Biondi; Maria Mormile; Fabrizio Banci Buonamici; Eugenio Di Giorgio; Marco Spadafora; Paolo Tini; Roberta Grassi; Luigi Pirtoli; Pierpaolo Correale; Salvatore Cappabianca; Roberto Grassi
Journal:  Med Oncol       Date:  2020-03-31       Impact factor: 3.064

6.  Neck emphysema in a HNSCC cancer patient undergoing concurrent radiotherapy and cetuximab.

Authors:  Valerio Nardone; Maria Grazia Calvanese; Ida D'Onofrio; Mario Di Stasio; Claudio Vitale; Antonia Silvestri; Bruno Daniele; Pierpaolo Correale; Paolo Fierro; Giuseppe Tortoriello; Alfonso Reginelli; Salvatore Cappabianca; Cesare Guida
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-12

7.  Osthole sensitizes with radiotherapy to suppress tumorigenesis of human nasopharyngeal carcinoma in vitro and in vivo.

Authors:  Lin Peng; Yi-Teng Huang; Jian Chen; Yi-Xuan Zhuang; Fan Zhang; Jiong-Yu Chen; Li Zhou; Dong-Hong Zhang
Journal:  Cancer Manag Res       Date:  2018-11-08       Impact factor: 3.989

8.  NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study.

Authors:  Xialin Chen; Xiang Zhu; Jianfang Wang; Jianjiang Liu; Rong Ji
Journal:  Onco Targets Ther       Date:  2019-02-22       Impact factor: 4.147

9.  3D bone texture analysis as a potential predictor of radiation-induced insufficiency fractures.

Authors:  Valerio Nardone; Paolo Tini; Stefania Croci; Salvatore Francesco Carbone; Lucio Sebaste; Tommaso Carfagno; Giuseppe Battaglia; Pierpaolo Pastina; Giovanni Rubino; Maria Antonietta Mazzei; Luigi Pirtoli
Journal:  Quant Imaging Med Surg       Date:  2018-02

10.  Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer).

Authors:  Maria Antonietta Mazzei; Letizia Di Giacomo; Giulio Bagnacci; Valerio Nardone; Francesco Gentili; Gabriele Lucii; Paolo Tini; Daniele Marrelli; Paolo Morgagni; Gianni Mura; Gian Luca Baiocchi; Frida Pittiani; Luca Volterrani; Franco Roviello
Journal:  Quant Imaging Med Surg       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.